Hilal Mahmood Fanasch, MD
Hematology & Oncology Physician · Nampa, ID
Hilal Mahmood Fanasch, MD is a hematology & oncology physician with a practice address in Nampa, Idaho, and NPI 1295857720, issued on Apr 4, 2007. Check the license (Idaho MC-2502, as entered in NPPES) on the Idaho Board of Medicine; the Medicare figures below come from public CMS files.
- Name
- Hilal Mahmood Fanasch
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License numbers
- MC-2502 ID
CDRH.0061344 CO
04-49199 KS
K1430 TX
Self-reported in NPPES; status is on the state search - Practice location
- 4400 E Flamingo Ave Ste 130, Nampa, ID 83687
- Phone
- (208) 205-0350
- Enumerated
- Apr 4, 2007
- Record last updated
- Mar 31, 2025
- Fax
- (208) 205-0356
- Medicaid ID
- 122170708 TX
- Medicare enrollment
- Enrolled (PECOS I20040715000666); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 38 in Idaho → Look up another NPI →
Also registered at 4400 E Flamingo Ave Ste 130
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Savanah Hawkins, PA-CPhysician Assistant1629551296
- Ian Qureshi, D.O., PH.D.Hematology & Oncology Physician1871934547
- Jasmine Streight, NPNurse Practitioner1538819982
- Holly Swensen, NPNurse Practitioner1386672012
Verify Hilal Mahmood Fanasch in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersIdaho Board of Medicine
Search for license MC-2502Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
88% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
102 Medicare Part D claims for 48 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 51% of claims.
Most prescribed
- Eliquis39 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $348.21
7 payments; by number, the most common kind was food and beverage; the largest payer was Bayer Healthcare Pharmaceuticals Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Hendrick Provider NetworkBrownwood, TX
- Utmb Faculty Group PracticeGalveston, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Hilal Mahmood Fanasch among 38 hematology & oncology physician records in Idaho
Hilal Mahmood Fanasch, MD is one of 38 hematology & oncology physician records with a practice address in Idaho. 89% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 39% of them.
- NPI issued2007 · 39% of these records are older, 45% newer
- In a Medicare fileYes · 89% of these records are
- In the CMS Doctors and Clinicians fileYes · 76% of these records are
- Graduated1979 · median 2006 among the 29 with a school on file
- Record last updated2025 · 45% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Idaho practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Idaho
There are 38 hematology & oncology physician records in Idaho.
All 38 in Idaho → Every provider in Nampa → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Ian Qureshi, D.O., PH.D.Nampa, ID 836871871934547
- Larry Fiorentino, MDNampa, ID 836861528086402
- Olga Derman, M.D.Boise, ID 837021356553101
- Andrew Dysart, MDBoise, ID 837061821674995
- Nicholas GordenBoise, ID 837061568805810
- Andrew Pierson, MDBoise, ID 837061992760664
- Kerry Pulver, MD,PHDBoise, ID 837061376596247
- Neda ShefaBoise, ID 837061457980708
Common questions
What is Hilal Mahmood Fanasch, MD's NPI number?
Hilal Mahmood Fanasch, MD's National Provider Identifier (NPI) is 1295857720, issued on Apr 4, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Hilal Mahmood Fanasch, MD located?
The NPPES record lists a practice address at 4400 E Flamingo Ave Ste 130, Nampa, ID, 83687. Phone: (208) 205-0350. Providers update this record themselves, so call before visiting.
How can I verify Hilal Mahmood Fanasch, MD's license?
NPPES lists Idaho license number MC-2502, as entered by the provider. Search the Idaho Board of Medicine at https://dopl.idaho.gov/bom/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Hilal Mahmood Fanasch, MD prescribe under Medicare Part D?
In 2024, Hilal Mahmood Fanasch, MD had 102 Medicare Part D claims for 48 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.